Kevin Hill – Cannabis and CBD in 2023
Dr. Kevin Hill is Director of Addiction Psychiatry at Beth Israel Deaconess Medical Center (BIDMC) an Associate Professor of Psychiatry at Harvard Medical School. He earned a Master’s in Health Science at the Robert Wood Johnson Clinical Scholars Program at the Yale School of Medicine. He most commonly treats patients who have problems with alcohol, cannabis, or opioids and has been named one of Boston Magazine’s Top Doctors for the past five years. He treats professional athletes from the National Football League (NFL), the National Basketball Association, and the Boston Red Sox, as well as airline pilots. The author of Marijuana: The Unbiased Truth about the World’s Most Popular Weed (Hazelden 2015) and co-author of Medical Cannabis: An Evidence-Based Guide (Wolters-Kluwer 2020), Dr. Hill’s research interests include the development of medications to treat cannabis use disorder as well as cannabis policy, and he has published widely on these topics in such journals as JAMA, The American Journal of Psychiatry, JAMA Internal Medicine, and Lancet Psychiatry.
Cannabis and CBD in 2023
Cannabis policy continues to evolve in the United States. Millions of Americans are using cannabis and cannabinoids like CBD despite not having a clear understanding of their risks and benefits. This presentation will outline state of the science for the risks and benefits of cannabis and cannabinoids like CBD.
At the conclusion of this training, participants will be able to:
- To identify FDA-approved cannabinoids and their medical indications
- To discuss the effects of cannabis on common psychiatric conditions
- To review risks and benefits of CBD use.